These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9629128)

  • 1. Molecular evolution of ligand-binding specificity in the vasopressin/oxytocin receptor family.
    van Kesteren RE; Geraerts WP
    Ann N Y Acad Sci; 1998 May; 839():25-34. PubMed ID: 9629128
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of agonist binding sites of vasopressin and oxytocin receptors.
    Mouillac B; Chini B; Balestre MN; Jard S; Barberis C; Manning M; Tribollet E; Trumpp-Kallmeyer S; Hoflack J; Elands J
    Adv Exp Med Biol; 1995; 395():301-10. PubMed ID: 8713980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and functional characterization of the amphibian mesotocin receptor, a member of the oxytocin/vasopressin receptor superfamily.
    Akhundova A; Getmanova E; Gorbulev V; Carnazzi E; Eggena P; Fahrenholz F
    Eur J Biochem; 1996 May; 237(3):759-67. PubMed ID: 8647123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of ligand binding and receptor activation in the oxytocin and vasopressin receptor family.
    Chini B; Fanelli F
    Exp Physiol; 2000 Mar; 85 Spec No():59S-66S. PubMed ID: 10795907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin and oxytocin receptors in the central nervous system.
    Barberis C; Tribollet E
    Crit Rev Neurobiol; 1996; 10(1):119-54. PubMed ID: 8853957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular recognition of peptide and non-peptide ligands by the extracellular domains of neurohypophysial hormone receptors.
    Howl J; Wheatley M
    Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):577-82. PubMed ID: 8713088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking-based test for affinities of two ligands toward vasopressin and oxytocin receptors.
    Slusarz R; Kaźmierkiewicz R; Giełdoń A; Lammek B; Ciarkowski J
    Acta Biochim Pol; 2001; 48(1):131-5. PubMed ID: 11440162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin and oxytocin: molecular biology and evolution of the peptide hormones and their receptors.
    Mohr E; Meyerhof W; Richter D
    Vitam Horm; 1995; 51():235-66. PubMed ID: 7483323
    [No Abstract]   [Full Text] [Related]  

  • 9. The emergence of the vasopressin and oxytocin hormone receptor gene family lineage: Clues from the characterization of vasotocin receptors in the sea lamprey (Petromyzon marinus).
    Mayasich SA; Clarke BL
    Gen Comp Endocrinol; 2016 Jan; 226():88-101. PubMed ID: 26764211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenesis and the study of expression, cellular targeting and function of oxytocin, vasopressin and their receptors.
    Young WS; Gainer H
    Neuroendocrinology; 2003 Oct; 78(4):185-203. PubMed ID: 14583651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a single residue responsible for agonist selectivity in the oxytocin-vasopressin receptors.
    Chini B; Mouillac B; Ala Y; Balestre MN; Trumpp-Kallmeyer S; Hoflack J; Elands J; Hibert M; Manning M; Jard S; Barberis C
    Ann N Y Acad Sci; 1997 May; 812():218-21. PubMed ID: 9186749
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological lineage analysis revealed the binding affinity of broad-spectrum substance P antagonists to receptors for gonadotropin-releasing peptide.
    Arai K; Kashiwazaki A; Fujiwara Y; Tsuchiya H; Sakai N; Shibata K; Koshimizu TA
    Eur J Pharmacol; 2015 Feb; 749():98-106. PubMed ID: 25592317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the activation and ligand recognition of the human oxytocin receptor.
    Waltenspühl Y; Ehrenmann J; Vacca S; Thom C; Medalia O; Plückthun A
    Nat Commun; 2022 Jul; 13(1):4153. PubMed ID: 35851571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking ligands to vasopressin and oxytocin receptors via genetic algorithm.
    Politowska E; Drabik P; Kazmierkiewicz R; Ciarkowsk J
    J Recept Signal Transduct Res; 2002; 22(1-4):393-409. PubMed ID: 12503629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule ligands for oxytocin and vasopressin receptors.
    Freidinger RM; Pettibone DJ
    Med Res Rev; 1997 Jan; 17(1):1-16. PubMed ID: 8979247
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.
    Chini B; Mouillac B; Ala Y; Balestre MN; Cotte N; Trumpp-Kallmeyer S; Hoflack J; Elands J; Hibert M; Manning M
    Adv Exp Med Biol; 1995; 395():321-8. PubMed ID: 8713982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural bases of vasopressin/oxytocin receptor function.
    Barberis C; Mouillac B; Durroux T
    J Endocrinol; 1998 Feb; 156(2):223-9. PubMed ID: 9518866
    [No Abstract]   [Full Text] [Related]  

  • 18. Reconstructing the evolutionary history of the oxytocin and vasotocin receptor gene family: Insights on whole genome duplication scenarios.
    Theofanopoulou C
    Dev Biol; 2021 Nov; 479():99-106. PubMed ID: 34329619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal nomenclature for oxytocin-vasotocin ligand and receptor families.
    Theofanopoulou C; Gedman G; Cahill JA; Boeckx C; Jarvis ED
    Nature; 2021 Apr; 592(7856):747-755. PubMed ID: 33911268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.